Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer.

Jin Sun LeeSusan E YostSuzette BlanchardDaniel SchmolzeHongwei Holly YinRaju PillaiKim RobinsonAileen TangNorma MartinezJana PortnowWei WenJohn H YimHeather Ann BrauerYuqi RenThehang LuuJoanne MortimerYuan Yuan

Published in: Breast cancer research : BCR (2019)

ClinicalTrials.gov, NCT02120469. Registered 18 April 2014.

Keyphrases

clinical trial
phase ii
metastatic breast cancer
open label
double blind
phase iii
study protocol
randomized controlled trial
placebo controlled